Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Myung Ji GohDong Hyun SinnSeonwoo KimSook Young WooHyun ChoWonseok KangGeum-Youn GwakYong-Han PaikMoon Seok ChoiJoon Hyeok LeeKwang Cheol KohSeung Woon Paik

Published in: Hepatology (Baltimore, Md.) (2020)

Statin use was associated with a reduced risk of HCC development in chronic HBV-infected patients, suggesting that statins may have a chemopreventive role in this population. These findings warrant a prospective evaluation.

Keyphrases

hepatitis b virus
cardiovascular disease
coronary artery disease
low density lipoprotein
liver failure
type diabetes
liver fibrosis
drug induced